Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 590859
                    [Title] => New hope for children with systemic juvenile idiopathic arthritis
                    [Summary] => 
Roche announced that new data being presented at the European League Against Rheumatism (EULAR) congress demonstrates that Actemra is highly effective in improving the signs and symptoms of systemic Juvenile Idiopathic Arthritis (sJIA), a severe childhood arthritis, where there are no currently licensed treatments.
                    [DatePublished] => 2010-07-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

SYSTEMIC

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 590859
                    [Title] => New hope for children with systemic juvenile idiopathic arthritis
                    [Summary] => 
Roche announced that new data being presented at the European League Against Rheumatism (EULAR) congress demonstrates that Actemra is highly effective in improving the signs and symptoms of systemic Juvenile Idiopathic Arthritis (sJIA), a severe childhood arthritis, where there are no currently licensed treatments.
                    [DatePublished] => 2010-07-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

New hope for children with systemic juvenile idiopathic arthritis

July 8, 2010 - 12:00am

Roche announced that new data being presented at the European League Against Rheumatism (EULAR) congress demonstrates that Actemra is highly effective in improving the signs and symptoms of systemic Juvenile Idiopathic...

Science and Environment